Evidence map›Paper›PMID 39499378›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases.

Yoshifumi Uwamino, Naoki Hasegawa, Yuka Kamoshita, Rika Inose, Wataru Aoki, Mika Nagata, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A Novel nor@DHB Matrix for Direct Microbial Analysis in Lung Cancer Tissues.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Non-InvasivePharmaceutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yoshifumi UwaminoDepartment of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomchi, Shinjuku-ku, Tokyo, 160-8582, Japan. uwamino@keio.jp.
Naoki HasegawaDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Yuka KamoshitaDepartment of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomchi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Rika InoseClinical Laboratory, Keio University Hospital, Tokyo, Japan.
Wataru AokiClinical Laboratory, Keio University Hospital, Tokyo, Japan.
Mika NagataClinical Laboratory, Keio University Hospital, Tokyo, Japan.
Ho NamkoongDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Tomoyasu NishimuraKeio University Health Center, Tokyo, Japan.
Hiromichi MatsushitaDepartment of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomchi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Funding

Japan Science and Technology Agency JPMJPR22R2Japan Society for the Promotion of Science JP 21K08515
6 · The paper itself

Abstract

purposeMycobacterial liquid culturing typically requires six weeks or longer, primarily because of the slow growth rate of Mycobacterium tuberculosis. This study aimed to evaluate the potential of shortening the duration of mycobacterial liquid culturing in healthcare settings with high prevalence rates of non-tuberculous mycobacteria.

methodsWe retrospectively analyzed the relationship between mycobacterial species and time to positive testing of liquid cultures from sputum samples using the Mycobacteria Growth Indicator Tube system over a 3.5-year period beginning in July 2020 at a university hospital in Japan.

resultsWe analyzed 15,147 sputum culture samples and found a 1.1% positivity rate for Mycobacterium tuberculosis complex, while the rates for Mycobacterium avium complex and Mycobacterium abscessus were 17.6% and 2.1%, respectively. The median time to positivity was 17 days for Mycobacterium tuberculosis complex, 9 days for Mycobacterium avium complex, and 4 days for Mycobacterium abscessus. Comparing a 4-week culture period with an eight-week period, the positivity rates for Mycobacterium avium complex and Mycobacterium abscessus were 97.0% and 99.4%, respectively.

conclusionIn settings with a high incidence of non-tuberculous mycobacteria, the basic liquid culturing period can be safely shortened to 4 weeks without significantly compromising detection sensitivity, except for the samples that are highly suspected to contain tuberculosis, extremely slow-growing mycobacteria, smear-positive, or nucleic acid amplification testing positive.

Indexed as

Bacteriological TechniquesLung DiseasesMycobacterium abscessusMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionMycobacterium Infections, NontuberculousAgedFemaleHumansJapanMaleMiddle AgedRetrospective StudiesSputumTime FactorsIncubation periodLiquid cultureMycobacerium abscessusMycobacterial cultureMycobacterium avium complexTime to positivity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.